The tunica adventitia of human arteries and veins as a source of mesenchymal stem cells by Corselli, Mirko et al.
  
 
 
 
Edinburgh Research Explorer 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
The tunica adventitia of human arteries and veins as a source of
mesenchymal stem cells
Citation for published version:
Corselli, M, Chen, C-W, Sun, B, Yap, S, Rubin, JP & Péault, B 2012, 'The tunica adventitia of human
arteries and veins as a source of mesenchymal stem cells' Stem Cells and Development, vol 21, no. 8, pp.
1299-308. DOI: 10.1089/scd.2011.0200
Digital Object Identifier (DOI):
10.1089/scd.2011.0200
Link:
Link to publication record in Edinburgh Research Explorer
Document Version:
Publisher's PDF, also known as Version of record
Published In:
Stem Cells and Development
Publisher Rights Statement:
 The author retains the right to deposit the publisher's PDF into institutional repository.
General rights
Copyright for the publications made accessible via the Edinburgh Research Explorer is retained by the author(s)
and / or other copyright owners and it is a condition of accessing these publications that users recognise and
abide by the legal requirements associated with these rights.
Take down policy
The University of Edinburgh has made every reasonable effort to ensure that Edinburgh Research Explorer
content complies with UK legislation. If you believe that the public display of this file breaches copyright please
contact openaccess@ed.ac.uk providing details, and we will remove access to the work immediately and
investigate your claim.
Download date: 28. Apr. 2017
The Tunica Adventitia of Human Arteries and Veins
As a Source of Mesenchymal Stem Cells
Mirko Corselli,1,2 Chien-Wen Chen,1 Bin Sun,1 Solomon Yap,1 J. Peter Rubin,3 and Bruno Pe´ault1,2,4,5
We previously demonstrated that human pericytes, which encircle capillaries and microvessels, give rise in
culture to genuine mesenchymal stem cells (MSCs). This raised the question as to whether all MSC are derived
from pericytes. Pericytes and other cells defined on differential expression of CD34, CD31, and CD146 were
sorted from the stromal vascular fraction of human white adipose tissue. Besides pericytes, CD34 + CD31-
CD146- CD45- cells, which reside in the outmost layer of blood vessels, the tunica adventitia, natively expressed
MSC markers and gave rise in culture to clonogenic multipotent progenitors identical to standard bone marrow-
derived MSC. Despite common MSC features and developmental properties, adventitial cells and pericytes
retain distinct phenotypes and genotypes through culture. However, in the presence of growth factors involved
in vascular remodeling, adventitial cells acquire a pericytes-like phenotype. In conclusion, we demonstrate the
co-existence of 2 separate perivascular MSC progenitors: pericytes in capillaries and microvessels and adventitial
cells around larger vessels.
Introduction
The in vitro generated mesenchymal stem cell (MSC)experimentally differentiates into mesodermal lineage
cells and canmodulate some immune responses [1,2]. Initially
extracted from the bone marrow, MSC can be derived from
most if not all organs, which may reflect the existence of a
systemic reservoir of multipotent progenitor cells [3–5].
However, the in vivo counterpart of the artificial MSC is still
not fully characterized [6–8]. An affiliation between MSC and
vascular cells has been suggested by the isolation of MSC
from artery or vein walls and, less directly, by the correlation
between MSC progenitor frequency and vessel density in
equine adipose tissue [9]. In the bone marrow, CD146+
reticular cells lining the endothelium in sinusoid walls can
self-renew, differentiate into bone, and recapitulate the he-
matopoietic microenvironment in vivo [10]. Similarities be-
tweenMSC and perivascular cells have been also described in
the dental pulp, endometrium, and several other tissues [11–
14].We recently demonstrated a perivascular origin of human
MSC, thus showing that pericytes purified from multiple or-
gans natively display phenotypic and developmental features
of MSC [15]. Moreover, cultured pericytes resemble MSC by
morphology and growth properties, retain the expression of
MSC surface markers, and can differentiate into bone, carti-
lage, fat, andmuscle cells, similar toMSC [15]. AlthoughMSC
can clearly derive from cultured pericytes, there is no argu-
ment to exclude that other cell types, including other vascular
cells, are also at the origin of MSC [16]. In the current study,
we investigated whether other cells share with pericytes the
ability to originateMSC. To address this question, we purified
different subsets of cells distinct from pericytes from the
stromal vascular fraction of human white adipose tissue
(hWAT) and tested their ability to yield MSC in culture. We
here report the identification of a novel perivascular MSC
progenitor, typified as CD34+CD31-CD146-CD45- and lo-
cated in the tunica adventitia of arteries and veins in multiple
human tissues, hence distinct from pericytes. Although the
presence of multipotent progenitors in the tunica adventitia
has been suggested by several studies [17–29], ignorance of
their antigenic phenotype has precluded the isolation and
characterization of these progenitors from human organs.
Materials and Methods
Human tissues
Human adipose tissue surgical specimens (n = 18) and li-
poaspirates (n= 15) were obtained from female patients un-
dergoing abdominoplasty and liposuction, respectively.
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Specimens were obtained as anonymous and unidentified
samples; no IRB approval was, therefore, required. Human
fetal tissues were obtained after spontaneous, voluntary, or
therapeutic pregnancy interruptions performed at Magee-
Womens Hospital (University of Pittsburgh), in compliance
with Institutional Review Board protocol number 0506176.
Cell sorting
The stromal vascular fraction of hWAT was analyzed by
flow cytometry, and different populations of cells were sor-
ted. Surgical hWAT was minced, whereas lipoaspirate was
diluted with an equal volume of PBS before digestion with
Dulbecco’s modified Eagle’s medium (DMEM) containing
3.5% bovine serum albumin (Sigma) and collagenase II
(1mg/mL; Sigma) for 70min under agitation at 37C. Adi-
pocytes were separated by centrifugation and removed.
Pellets were resuspended in erythrocyte lysis buffer (155mM
NH4Cl, 10mM KHCO3, and 0.1mM EDTA) and incubated
for 10min at room temperature. After centrifugation, pellets
were resuspended in PBS and passed through a 70-mm cell
filter (BD Biosciences). Fetal tissues were processed as pre-
viously described [15]. Cells were incubated with uncoupled
anti-CD31 (DAKO; 1:50), then with biotinylated goat anti-
mouse Ig (DAKO; 1:500) followed by incubation with
streptavidin-PE-Texas Red (BD Biosciences; 1:500). Cells
were eventually incubated with a mixture of the following
directly conjugated antibodies: anti-CD34-PE (DAKO; 1:100),
anti-CD45-APC (Santa Cruz Biotechnologies; 1:100), and
anti-CD146-FITC (AbD Serotec; 1:100). All incubations were
performed at 4C for 15min in the dark. Before sorting, DAPI
(Invitrogen; 1:1000) was added for dead cell exclusion, the
solution was then passed through a 70-mm cell filter and then
run on a FACSAria cell sorter (BD Biosciences). Sorted cells
were plated at a density of twenty thousand cells per cm2 in
0.2% gelatin-coated plates and cultured at 37C in EGM2
(Lonza) for the first 2 weeks. Next, cells were cultured in
DMEM high glucose, 20% fetal calf serum (FCS; Invitrogen),
and 1% penicillin/streptomycin (BD Biosciences).
RT-PCR analysis
Total RNAs were extracted from a minimum of 2· 104
freshly sorted or cultured cells by using Absolutely RNA
nanoprep kit (Stratagene), and cDNAs were synthesized
with SuperScript II reverse transcriptase (Invitrogen) ac-
cording to manufacturer’s instructions. PCR was performed
with Taq polymerase (Invitrogen) per manufacturer’s in-
structions for 35 cycles at 58C annealing temperature, and
PCR products were electrophoresed on 1% agarose gels.
Flow cytometry analysis
Cultured cells were labeled with the following commer-
cial antibodies: anti-CD34-PE (BD Biosciences; 1:100), anti-
CD44-PerCP-Cy5.5 (eBioscience; 1:100), anti-CD73-PE (BD
Biosciences; 1:50), anti-CD90-APC (BD Biosciences; 1:50),
anti-CD105-PE (Invitrogen; 1:50), and anti-CD146-PE (BD
Biosciences; 1:100). Cells were then washed twice, and at
least 50,000 events were acquired on an FACSCanto II
cytometer (BD Biosciences). Each individual adventitial cell
culture (n = 8) was analyzed at different passages (p3 to
p13).
Immunohistochemistry and immunocytochemistry
hWAT samples were impregnated in gelatin/sucrose,
frozen in isopentane (Sigma) cooled in liquid nitrogen and
embedded in tissue freezing medium (Triangle Biomedical
Sciences). Five- to 9-mm sections were cut on a cryostat
(Microm) and fixed for 5min with 50% acetone (VWR In-
ternational) and 50% methanol (Fischer Scientific). Sections
were then dried at room temperature and washed thrice for
5min in PBS. Nonspecific binding sites were blocked with
5% goat serum (Invitrogen) in PBS for 1 h at room temper-
ature. Sections were incubated with uncoupled primary an-
tibodies overnight at 4C, or 2 h at room temperature in the
case of directly coupled antibodies. After rinsing, sections
were incubated for 1 h at room temperature with a biotiny-
lated secondary antibody, then with fluorochrome-coupled
streptavidin, both diluted in 5% goat serum in PBS. The same
protocol was used for the staining of cultured cells at dif-
ferent passages. The following uncoupled anti-human pri-
mary antibodies were used: anti-CD146 (BD Biosciences;
1:100), anti-CD31 (DAKO; 1:100), anti-CD34 (BD Biosciences;
1:50), anti-CD44, anti-CD73, anti-CD105 (all from Invitrogen;
1:20), anti-CD90 (BD Biosciences; 1:20), anti-NG2 (1:100; BD
Biosciences), and anti-PDGFR-b (1:50; Cell Signaling) and
anti-vimentin (1:100; Sigma). Coupled antibodies used
included the following: anti-a-SMA-FITC (Sigma; 1:100),
anti-CD34-FITC (Miltenyi; 1:20), and anti-vWF-FITC (US
Biological; 1:100). Human specific anti-dystrophin (Novo-
castra; 1:20) was used to detect dystrophin-positive myofi-
bers in SCID/mdx mouse muscle sections. Secondary goat
anti-mouse antibodies were biotinylated (DAKO; 1:500) or
coupled to Alexa 488 (Molecular Probes; 1:500). Streptavidin-
Cy3 (Sigma; 1:500) was used after the incubation with bio-
tinylated secondary antibodies. Nuclei were stained with
DAPI (4’, 6-diamino-2-phenylindole dihydrochloride, Mole-
cular Probes; 1:2000) for 5min at room temperature. An
isotype-matched negative control was performed with each
immunostaining. Slides were mounted in glycerol-PBS (1:1;
Sigma) and observed and photographed on an epi-
fluorescence microscope (Nikon Eclipse TE 2000-U).
Confocal microscopy analysis
Tissue sections were examined by confocal microscopy after
multi-color immunofluorescence staining and DAPI nuclear
staining. Human WAT frozen sections were stained with anti-
CD34, -CD146, -a-SMA, or -vWF antibodies according to the
protocol just described. Images were collected on an Olympus
Fluoview 1000 confocal microscope with 40· , 60· , and 100·
oil immersion objectives. Excitation wavelengths used for de-
tection included 405, 488, 543, and 633nm for DAPI, FITC,
Cy3, and Cy5, respectively. Sequential detection was set to
eliminate bleed-through artifacts between fluorophores.
Population doubling time calculation
Sorted cells cultured in DMEM + 20% FCS for 12 weeks
were seeded into 6-well plates at a density of 2.0 · 103 cells/
cm2. Cells were grown for 120 h, and the population dou-
bling time was calculated by using the formula: time/no. of
doublings, where time = 120, and no. of doublings = log2 (N
final/N initial). The assay was performed in biological and
technical triplicates.
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Differentiation into mesodermal cell lineages in vitro
For adipogenic differentiation, adventitial cells at 70% con-
fluence were cultured in DMEM, 10% FCS, 1mM dexametha-
sone, 0.5mM isobutylmethylxanthine, 60mM indomethacine,
and 170mM insulin (all from Sigma). After 14 days, cells were
fixed in 2% PFA at room temperature, washed in 60% iso-
propanol, and incubated with Oil red O for 10min at room
temperature for detection of lipid accumulation. Cells at 70%
confluence not cultivated in adipogenic differentiation medium
were fixed and stained as described for use as a negative control.
For chondrogenesis, high-density pellets were prepared by
spinning down 3·105 cultured cells in 15mL conical tubes and
grown in serum-free DMEM containing an insulin-transferrin-
selenious acid mix (BD Biosciences), 50mg/mL L-ascorbic acid
2-phosphate (Wako), 100mg/mL sodium pyruvate, 40mg/mL
L-proline (both from Invitrogen), 0.1mM dexamethasone (Sig-
ma), and 10ng/mL transforming growth factor b1 (TGF-b1)
(Peprotech). Pellets cultured in the absence of TGF-b1 were
considered as untreated and used as negative controls. After 21
days, pellets were fixed in 10% formalin, dehydrated using a
graded series of ethanol washes, and embedded in paraffin.
Five micrometers thick sections were rehydrated and stained
with Alcian blue and nuclear fast red for the detection of sul-
fated glycosaminoglycans and nuclei, respectively.
For osteogenic differentiation, cells at 70% confluence were
cultivated in osteogenic medium, consisting of DMEM, 10%
FCS, 0.1mM dexamethasone, 50mg/mL L-ascorbic acid, and
10mM b-glycerophosphate (all from Sigma). After 21 days,
cells were fixed in 4% formaldehyde for 2min and incubated
for 10min with alizarin red, pH 4.2 for the detection of cal-
cium deposits. All the cell cultures (n= 8) were assayed for
their developmental potential in technical triplicate.
Cell cloning
Clones were obtained by limiting dilution after plating
cultured adventitial cells at a density of 1 cell/well in a 96
multi-well plate. Clones were grown from 2 different speci-
mens at passages 5 and 10. A total of 5 plates (480-wells) were
used for each cloning. Clones that reached confluence were
expanded, and 5 individual clones obtained from each hWAT
specimen were randomly selected and assayed for their phe-
notype and in vitro developmental potential as just described.
Differentiation into pericyte-like cells
Five thousand cultured adventitial cells were plated in
48-well plates in DMEM high glucose, 20% FCS, and 1%
penicillin-streptomycin. When at 70% confluence, cells were
cultured in DMEM high glucose, 0.5% FCS, 0.1 mM angio-
poietin II (ANGPT2), and 1% penicillin-streptomycin for
72 h. Cells were then washed with PBS, fixed with cold
methanol-acetone (1:1), and stained with anti-a-SMA, anti-
CD146, anti-PDGFR-b, and anti-NG2 as described earlier.
The assay was performed at different passages (p5 to p10) in
biological duplicate and technical triplicate.
Statistical analysis
Results are expressed as mean– SEM. Unpaired t-test
was used to compare the means between 2 groups, and a P
value < 0.05 was considered significant.
Results
MSC can be derived from adipose tissue CD34 +
cells distinct from pericytes
We recently described primary MSCs within human or-
gans as CD146 +CD34-CD45-CD56- pericytes. Here, we set
up to verify whether the whole potential to give rise to MSC
in culture is confined within pericytes. To this end, we in-
vestigated the potential of a different sets of cells, distinct
from pericytes and isolated from the stromal vascular
fraction of hWAT, a well-documented source of adult
multipotent cells, to give rise to MSC in culture. After ex-
clusion of hematopoietic (CD45 + ) and dead (DAPI + ) cells,
3 distinct populations could be detected by flow cytometry
based on expression of CD34 and CD146. We isolated
pericytes as CD146 +CD34- cells (Fig. 1a, gray box), as well
as a mixture of other cells differentially expressing CD34
and CD146 (Fig. 1a, black box). Outgrowth of MSCs was
observed from both cultured populations. As shown in
Fig. 1b, we then separated the 2 nonpericyte subpopulations
defined as CD34 +CD146- and CD34 +CD146 + . Cultivated
CD34 +CD146 + cells never gave rise to MSC, whereas
MSC-like cells arose from CD34 +CD146- cells in vitro. The
endothelium-specific antigen CD31 was detected in only
CD34 +CD146 + cells; thus, no endothelial cells are present
within CD34 +CD146- progenitors of MSC (Fig. 1c). Long-
term cultures of CD34 +CD31-CD146- cells, representing
9.8 – 1.7% of the total stromal vascular fraction, were suc-
cessfully established as MSC from all specimens processed
for this purpose (n = 12). To exclude the possibility of a
contamination by pericytes, the purity of CD34 +CD31-
CD146- cells was verified immediately after the sort by
RT-PCR analysis, and no CD146 expression was ever
detected (Fig. 1d). Further, sorted cells expressed CD34 but
not CD31 or CD144 (VE-cadherin), thus confirming that
the purified CD34 +CD31-CD146- cells are distinct from
pericytes and endothelial cells.
CD34 + CD146- cells are presented
in multiple organs
We next investigated whether this novel population of
MSC progenitors is hWAT specific or rather present in
multiple organs. Using the sorting strategy just described for
hWAT, we detected the same population of CD34+CD146-
cells also in fetal muscle, lung, and bone marrow (Fig. 2a–c).
MSC-like cells were obtained in cultures regardless of the
tissue of origin, thus demonstrating that CD34 +CD146- cells
are MSC progenitors distinct from pericytes distributed in
different tissues.
CD34 + CD146- cells display MSC features
at the clonal level
MSC are culture-established clonogenic progenitors char-
acterized by a distinct surface phenotype and the ability to
differentiate into mesodermal cell lineages. To investigate
whether CD34+CD146- cells meet the criteria for being MSC
ancestors, we cloned by limiting dilution CD34+CD146- cells
obtained from 2 different hWAT samples. Clones developed
with an efficiency of 15.6%– 1.5%, with differences in prolif-
eration potentials, which suggested that CD34+CD146- cells
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FIG. 1. Purification of nonpericyte MSC-like cells from human adipose tissue. (a) After exclusion of DAPI + dead cells and
CD45+ hematopoietic cells, pericytes were isolated as CD146+CD34- cells (gray gate) as previously described. MSC-like cells
could also be grown from the mixed population of nonpericyte cells differentially expressing CD34 and CD146 (black gate). (b)
The following nonpericyte cell populations were then purified: CD34 +CD146-, CD34 +CD146 + and cultured in MSC
conditions. The outgrowth of MSC-like cells was observed only after culture of CD34+CD146- cells. (c) Analysis of CD31
expression on gated CD34+CD146- cells (left dot plot) and CD34 +CD146 + cells (right dot plot). CD31 was detected in only
endothelial CD34+CD146+ cells, whereas no endothelial cells were detected within CD34 +CD146- cells. (d) RT-PCR
analysis was performed to check the purity of sorted CD34 +CD31-CD146- cells. CD34 but no CD31, CD144, and CD146
mRNA was detected, thus excluding a possible contamination by endothelial cells or pericytes. C, positive control (un-
fractionated stromal vascular fraction); S, freshly sorted CD34+CD146- cells. The same results were observed in 3 distinct
experiments. MSC, mesenchymal stem cell.
FIG. 2. CD34 +CD146- cells are present in multiple organs. Using the same sorting strategy described for the isolation of
MSC-like cells from WAT, CD34+D146- cells were detected in other tissues such as fetal muscle, lung, and bone marrow
(from left to right). MSC-like cells were obtained from CD34+CD146- cells regardless of the tissue of origin. WAT, white
adipose tissue.
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are heterogeneous. Only 2.7% – 1.7% of the clones formed
could be serially passaged and further characterized (Fig.
3a). All clones displayed the MSC hallmark markers CD44,
CD73, CD90, and CD105 at every passage tested, up to
passage 10 (Fig. 3b). All clones were also able to differen-
tiate in vitro into adipocytes, osteocytes, and chondrocytes,
as shown in Fig. 3c–e. No significant differences in pheno-
type and developmental potential were observed at differ-
ent passages in polyclonal cultures (p3-p10) or among
different clones. We, therefore, established that CD34 +
CD146- cells are genuine progenitors of MSC. The same
phenotype and developmental potential was observed in
adventitial cells isolated from fetal bone marrow and lung
(data not shown).
Native distribution of CD34 +CD146- cells
in human tissues
Immunohistochemistry was performed on sections of
WAT, adult and fetal muscle, adult pancreas, and fetal lung
to uncover the natural localization of CD34+CD146- cells.
We previously confirmed that, in capillaries (diameter: 8–
10mm), CD34 is exclusively expressed by endothelial cells
[15]. In the current study, the only cells expressing CD34, but
not CD31 and CD146, consistent with the FACS plot shown
in Fig. 1c (left panel), were located around blood vessels
larger than capillaries, spanning arterioles, venules, arteries,
and veins, with a diameter greater than 50mm. Together with
CD34, we used markers to detect endothelial cells (CD31)
and pericytes/smooth muscle cells (CD146 and a-SMA).
Double staining confirmed the co-expression of CD34 and
CD31 by all endothelial cells. Conversely, cells located in the
outmost layer of vessel walls express CD34 but not CD31
(Fig. 4a–c). Double stainings of CD34 and CD146 or a-SMA
were then performed to localize nonendothelial CD34 + cells.
As shown in Fig. 4d, e, a-SMA +CD146+ smooth muscle cells
are surrounded by CD34+ cells. No expression of CD34 by
pericytes/smooth muscle cells was ever observed, thus
confirming our previous observations [15]. By triple staining
and confocal microscopy analysis, we have typified the cells
that constitute the 3 layers of small to large vessel walls as
CD34+CD146-a-SMA- adventitial cells, CD146+ a-SMA +
FIG. 3. Cultured CD34+CD146- cells are clonogenic multipotent progenitors similar to MSC Representative character-
ization of a clone at late passage of culture (p10). The phenotype and developmental potential are maintained throughout
culture with no significant change after long-term culture. (a) Polyclonal cultured CD34 +CD146- cells were cloned by
limiting dilution. Only a minority of the single-cell clones could be expanded for further characterization. (b) Single cell-
derived clones homogeneously express typical MSC markers (CD105, CD44, CD90, and CD73). Red line: unstained negative
control sample; blue line: stained sample. (c–e) Single-cell clones can each differentiate into several mesodermal cell lineages
when cultured under specific conditions. Oil red O, alizarin red and alcian blue staining reveal differentiation into adipocytes
(c), osteocytes (d), and chondrocytes (e), respectively. Color images available online at www.liebertonline.com/scd
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CD34- pericytes/smooth muscle cells, and CD34+CD146+/
-a-SMA- endothelial cells (Fig. 4f). In conclusion, the ana-
tomic candidate marked as CD34 +CD31-CD146- is a vas-
cular adventitial cell.
Adventitial cells express MSC markers prior
to ex vivo culture
Flow cytometry analysis on freshly dissociated adipose
tissue revealed that stromal vascular fraction derived ad-
ventitial cells natively and homogeneously express the typ-
ical MSC markers CD44, CD73, CD105, and CD90 (Fig. 5a).
Immunohistochemical staining of serial sections from the
same adipose tissue confirmed that, besides microvascular
pericytes, the only other cells coexpressing CD44, CD90,
CD73, and CD105 are, indeed, distributed in the tunica
adventitia of larger blood vessels, surrounding a-SMA +
smooth muscle cells (Fig. 5b–e). Altogether, these results
indicate that adventitial cells are native progenitors of MSC,
anatomically distinct from pericytes and peripheral to blood
vessels larger than arterioles and venules.
Cultured adventitial cells treated with a vessel
remodeling growth factor acquire pericyte traits
The observation that adventitial cells and pericytes are
anatomically and phenotypically different, yet all give rise to
bona fide MSC in culture, prompted us to closely and com-
paratively follow both cells along extended in vitro expan-
sion. Despite similar morphologies, calculation of population
doubling times (PDT) after 12 weeks revealed that adventi-
tial cells proliferate significantly faster than pericytes (Fig.
6a). As of surface phenotype, adventitial cells isolated from 8
distinct hWAT samples expressed no CD146 at any passage
tested (up to p13), whereas all cultured pericytes did (Fig.
6b), as already reported [15]. No expression of CD34 was
detected in either population by flow cytometry (data not
shown). As previously demonstrated [15], human pericytes
express PDGFR-b, CD146, a-SMA, and NG2 (Fig. 6d–g),
none of which was ever detected in adventitial cells cultured
in regular conditions (Fig. 6i–l), in which the 2 cell types only
shared the expression of vimentin (Fig. 6h, m). However,
treatment with 0.1 mM ANGPT2 for 72 h induced expression
FIG. 4. In situ localization of CD34+CD31-CD146- cells. Immunohistochemistry was performed on hWAT frozen sections.
In vessels with a lumen diameter greater than 50 mm, CD31 is specifically expressed by endothelial cells in the tunica intima
(a, 20 · ), whereas CD34 is expressed by 2 distinct populations of differently located cells (b, 20· ). As shown by merging the 2
stainings, CD34 +CD31 + cells are endothelial, whereas a subset of CD34+CD31- cells is located in the outer layer of the
blood vessel (c, 20· ). Double staining of CD34 and pericyte/smooth muscle cell markers CD146 (d, 20· ) or a-SMA (e, 20· )
reveals that nonendothelial CD34 + cells are located in the tunica adventitia surrounding smooth muscle cells. Multi-color
staining was performed with antibodies against CD34 (red), CD146 ( purple), and a-SMA (green) to identify the 3 subsets of
cells constituting the vessel wall (f, 60 · ). Confocal microscopy confirmed that CD34-positive cells residing in the vascular
adventitia do not co-express CD146 or a-SMA. In contrast to adventitial cells, smooth muscle cells surrounding endothelial
cells express both CD146 and a-SMA. Endothelial cells are identified by their luminal localization and co-expression of CD34
and CD146 (f, 60 · ). Color images available online at www.liebertonline.com/scd
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of all the aforementioned markers in cultured adventitial
cells, thus suggesting differentiation into pericyte-like cells
(Fig. 5n–q).
Discussion
Historically, MSCs were isolated on their capacity to se-
lectively proliferate in cultures of total bone marrow and to
differentiate in mesodermal cell lineages. Some authors have
also described MSC differentiation into nonmesodermal cell
lineages, although this is still a matter of debate [30,31].
Remarkably though, MSC did not benefit the theoretical and
technologic progress that permitted the prospective identi-
fication of hematopoietic and other stem cells. The in-
strumentalization of MSC for tissue-engineering/cell therapy
eclipsed latent questions regarding the identity, origin, and
native distribution of these adult stem cells. Only recently
were similarities noticed to exist between MSC and peri-
vascular cells [10–14]. Indeed, vascular pericytes purified to
homogeneity from multiple organs express MSC markers,
can differentiate into mesoderm lineage cells, and give rise in
culture to genuine MSC [15]. Are all MSC derived from
pericytes, which are exclusively associated with capillaries
and microvessels [16]? The current work addressed this issue
along a substractive approach, by investigating the ability of
FACS selected nonpericyte cells, within the stromal vascular
fraction of hWAT, to give rise to MSC in culture. Our general
conclusion is that CD34+CD31-CD146-CD45- cells residing
in the outer layer (tunica adventitia) of arteries and veins yield
in culture multipotent progenitors functionally and anti-
genically similar to MSC. Coincidentally, the tunica adventitia
is believed to play a role in vascular remodeling and be
involved in the development of atherosclerosis [17–20]. Ad-
ventitial cells indeed proliferate, differentiate into myofi-
broblasts, and migrate into the inner layer of blood vessels in
response to injury or stress [21–25]. CD34 +CD31- cells lo-
cated in the ‘‘vasculogenic zone’’ of the thoracic artery, be-
tween the tunica media and tunica adventitia, can also give rise
to endothelium; hence, they could represent a resident pool
of endothelial progenitor cells for postnatal vasculogenesis
[26]. Multipotent progenitors can originate from larger ves-
sels not surrounded by typical pericytes, such as the human
pulmonary artery, fetal aorta wall, and vena saphena [27–
29], thus further supporting our present conclusions.
The presence in hWAT of CD34+ MSC progenitors has
been reported, although the native identity of these cells has
been controversial so far. Traktuev et al. described in adipose
tissue CD34 +CD31- perivascular cells that, once enriched by
plastic adherence and briefly cultured, expressed markers of
pericytes (PDGFR-b), MSC (CD90), and smooth muscle cells
FIG. 5. Adventitial cells express typical MSC markers before ex vivo expansion. (a) Flow cytometry analysis was performed
on fresh stromal vascular fraction before culture (n= 3). The expression of hallmark MSC markers was detected within the
subset of adventitial cells, previously defined as CD34+DAPI-CD45-CD31-CD146- (green box). Adventitial cells homoge-
neously express all the MSC markers tested. Red histogram line: unstained cells. Blue histogram line: stained cells. (b–e) Serial
staining of an adipose tissue artery with antibodies to a-SMA and MSC markers. All markers tested, CD90 (b), CD44 (c),
CD73 (d), and CD105 (e), are co-localized in the cell layer surrounding a-SMA + smooth muscle cells, thus confirming that
CD34 +CD31-CD146- multipotent progenitors reside in the tunica adventitia. As expected, CD105 and CD73 were also
expressed in endothelial cells (d, e). Color images available online at www.liebertonline.com/scd
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(a-SMA) [32]. In 2 other studies, CD34+CD31- cells were
clearly identified in human adipose tissue as adventitial cells
distinct from a-SMA + smooth muscle cells and PDGFR-b +
or CD146 + pericytes, all of which are invariably CD34
negative [33,34]. Adventitial cells and pericytes from fat,
therefore, include 2 anatomically and phenotypically distinct
perivascular primary MSC, an observation we have ex-
tended to human fetal lung, fetal and adult pancreas, and
adult muscle. Importantly, no potential to generate MSC was
observed, in any tissue analyzed, outside these 2 perivas-
cular cell compartments. Adventitial fibroblasts can differ-
entiate into a-SMA +myofibroblasts under hypoxia, or when
exposed to growth factors involved in vascular remodeling
and angiogenesis, TGF-b or angiotensin II [35–37]. Con-
sistently, adventitia-derived MSC treated with angiotensin II
upregulate the expression of a-SMA, which typifies fibro-
blasts, pericytes, smooth muscle cells, and myofibroblasts.
We also show for the first time that adventitial cells cultured
in the presence of angiotensin II upregulates other pericyte
markers: CD146, PDGFR-b, and NG2. The same outcome was
observed when adventitial cells were treated with angiopoie-
tin-2, a growth factor produced at the site of vascular re-
modeling that disrupts interactions between smooth muscle
cells and endothelial cells, thus leading to angiogenesis in
the presence of VEGF [38]. Altogether, our results indicate
the ability of adventitial cells to differentiate into pericytes-
like cells under appropriate signaling, thus supporting the
previously hypothesized existence of CD34+CD31- pericyte
FIG. 6. In vitro characterization of long-term cultured adventitial cells (a) After 12 weeks of culture, adventitial cells show a
significantly lower population doubling time (PDT) compared with pericytes (*P < 0.05) (b, c) At difference with pericytes,
cultured adventitial cells never express CD146. Red line: unstained negative control sample; blue line: stained sample. (d–q) As
previously reported, cultured pericytes express CD146 (d), a-SMA (e), PDGFR-b (f), and NG2 (g). None of these markers is
expressed by cultured adventitial cells (i–l). The 2 cell types only share expression of vimentin (h, m). When exposed to
0.1 mM angiopoietin 2 (ANGPT 2) for 72 h, adventitial cells acquired all pericyte markers: CD146, a-SMA, PDGFR-b, and NG2
(n–q). Color images available online at www.liebertonline.com/scd
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progenitors [39,40]. Differentiation into myofibroblasts sug-
gests that adventitial cells are precursors of smooth muscle
cells in homeostasis and disease, in agreement with the
emerging theory of vascular remodeling ‘‘from the outside-in,’’
as the adventitia being the sensor of vascular injury or other
environmental stress [41]. Given the observed capacity of ad-
ventitial cells to differentiate into MSC and pericyte-like cells,
here we propose a hypothesis: the centrifugal migration of
multipotent adventitial progenitors to surrounding regenerat-
ing tissues, in particular at the developing blood vessels.
In final conclusion, we have demonstrated that human
blood vessels, depending on their size, are associated with 2
distinct peripheral MSC progenitors, namely pericytes en-
circling capillaries and microvessels [15], and adventitial
cells surrounding larger arteries and veins. This hypothesis
of a dual origin for MSC is also supported by the presence of
both CD146+ cells (40%–60%) and CD146- cells within MSC
conventionally derived in culture [13]. We propose that, in
hWAT and presumably all organs, vascular progenitors of
MSC are hierarchically organized with adventitial cells being
precursors of pericytes, based on their higher proliferation
rate and potential to differentiate into pericytes on proper
stimulation.
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